AT339212T
Potentiation of the activity of sn-38 prodrugs
Abstract
(57) Summary book invention is the method of enhancing the activity of a prodrug intentionally statistically, without producing serious side effects, and offers a method including prescribing a polyanion for the patient with this prodrug.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
64 members in 11 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 16418299 | United States of America | P |
Members64
| Document | Office | Kind | |
|---|---|---|---|
| CA2229811A1 | Canada | A1 | |
| WO9706662A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6953896A | Australia | A | |
| CA2232724A1 | Canada | A1 | |
| WO9711171A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7241296A | Australia | A | |
| WO9706662A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5652356A | United States of America | A | |
| EP0846170A1 | European Patent Office (EPO) | A1 | |
| US5773601A | United States of America | A | |
| CA2283626A1 | Canada | A1 | |
| WO9840479A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6328598A | Australia | A | |
| JPH11512088A | Japan | A | |
| US5969117A | United States of America | A | |
| US5973136A | United States of America | A | |
| JPH11512601A | Japan | A | |
| EP1007656A1 | European Patent Office (EPO) | A1 | |
| EP1019428A2 | European Patent Office (EPO) | A2 | |
| CA2390975A1 | Canada | A1 | |
| WO0134093A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1474901A | Australia | A | |
| EP0846170B1 | European Patent Office (EPO) | B1 | |
| AT203271T | Austria | T | |
| ATE203271T1 | Austria | T1 | |
| DE69613984D1 | Germany | D1 | |
| WO0134093A3 | World Intellectual Property Organization (WIPO) | A3 | |
| DE69613984T2 | Germany | T2 | |
| JP2002501370A | Japan | A | |
| EP1229938A2 | European Patent Office (EPO) | A2 | |
| JP2003513894A | Japan | A | |
| US2003105035A1 | United States of America | A1 | |
| EP1019428B1 | European Patent Office (EPO) | B1 | |
| AT243706T | Austria | T | |
| ATE243706T1 | Austria | T1 | |
| DE69628864D1 | Germany | D1 | |
| EP1340765A2 | European Patent Office (EPO) | A2 | |
| DK1019428T3 | Denmark | T3 | |
| US6624293B1 | United States of America | B1 | |
| PT1019428E | Portugal | E | |
| ES2201198T3 | Spain | T3 | |
| DE69628864T2 | Germany | T2 | |
| US2004106570A1 | United States of America | A1 | |
| US2005054600A1 | United States of America | A1 | |
| WO2005115480A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1340765A3 | European Patent Office (EPO) | A3 | |
| WO2005115480A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US7074768B2 | United States of America | B2 | |
| EP1007656B1 | European Patent Office (EPO) | B1 | |
| EP1229938B1 | European Patent Office (EPO) | B1 | |
| AT339212TThis record | Austria | T | |
| AT339498T | Austria | T | |
| ATE339212T1 | Austria | T1 | |
| ATE339498T1 | Austria | T1 | |
| DE60030754D1 | Germany | D1 | |
| DE69835886D1 | Germany | D1 | |
| DE60030754T2 | Germany | T2 | |
| AT411333T | Austria | T | |
| ATE411333T1 | Austria | T1 | |
| EP1340765B1 | European Patent Office (EPO) | B1 | |
| JP4177455B2 | Japan | B2 | |
| DE69637718D1 | Germany | D1 | |
| ES2315442T3 | Spain | T3 | |
| CA2229811C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 977058
Titles2
- German
- POTENZIERUNG DER WIRKSAMKEIT VON SN-38-PRODROGEN
- English
- POTENTIATING THE EFFICACY OF SN-38 PRODROGEN
Classification
- CPC, 6
- A61K31/7088
- A61K31/4745
- A61K31/727
- A61K31/737
- A61P35/00
- A61P43/00
- IPC, 7
- A61K31 4745
- A61K31 7088
- A61K31 727
- A61K31 737
- A61K45 00
- A61P35 00
- A61P43 00